Centricity Research Toronto
Toronto, Ontario M9W 4L6
1 studies enrolling now · 6 studies all time
What they study most
Cytomegalovirus Infection, Obesity, Overweight, Type 1 Diabetes Mellitus With Hypoglycemia, Type 2 Diabetes, Type 2 Diabetes Mellitus
Studies at this site
- A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes — Recruiting now
- Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide — Running, not enrolling
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
- Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling